Capricor Therapeutics Inc (NASDAQ:CAPR) currently has a daily average trading volume of 2.08M but it saw 2616784 shares traded in last market. With a market cap of 564.03M USD, the company’s current market price of $12.34 came rising about 10.67 while comparing to the previous closing price of $11.15. In past 52 weeks, the stock remained buoying in the range of price level as high as $23.40 and as low as $3.52. In the recent trading on the day, stock has struck highest price mark of $11.1821 while lowest mark touched by it was $12.48.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Roth Capital which initiated the stock as “Buy” in its note to investors issued on May 20, 2025, recommending a price target of $31 for it. Oppenheimer also issued its recommendations for the stock as it initiated the price target for the stock is $14.
Over the week, CAPR’s stock price is moving 15.87% up while it is 19.81% when we observe its performance for the past one month. Year-to-date it is -10.58% down and over the past year, the stock is showing an upside performance of 117.25%.
Currently, Capricor Therapeutics Inc’s total number of outstanding shares is 45.68M with 16.80% of that held by the insiders while 40.57% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -41.90% and return on equity (ROE) at -75.39%. Stock’s beta reads 0.85. Stock has a price to book (P/B) ratio of 4.42 while price to sale or P/S ratio amounts to 32.49. Its return on asset (ROA) is -54.19% on average.
